- A reversal of the federal ban on the use of controversial pesticides linked to potential health disorders illustrates a pressing need for MustGrow’s patented technology for natural biopesticide solutions
- MustGrow’s research and development program focuses on a portfolio of natural biopesticides and biofertilizers, and it is expanding into the cannabis and tobacco industries
- Global crop protection is a multibillion-dollar market that’s expected to surge over the next five years
The Environmental Protection Agency’s recent decision to allow the use of two chemical pesticides – chlorpyrifos and sulfoxaflor, both made by Corteva Agriscience, formerly part of DowDuPont – highlights the importance of research into safe, natural biopesticides such as those now under development by MustGrow Biologics Corp. (CSE: MGRO).
Numerous organizations are pushing to ban the pesticides as harmful substances to humans and other living creatures. According to Reuters, studies show that exposure to chlorpyrifos is linked to low birth weight, reduced IQ, attention disorders and other issues in infants and children (http://ibn.fm/RvwlO). Likewise, The Associated Press reports that the use of sulfoxaflor is decimating beneficial insects such as the honeybee (http://ibn.fm/hQVwQ).
Agricultural biotech company MustGrow Biologics is developing and commercializing a portfolio of natural biopesticides and biofertilizers that may provide high quality, organic pest control to growers facing soil-borne diseases and pests that ruin crops, including those in the cannabis and tobacco industries. MustGrow’s patented products are refined from compounds of the mustard plant, utilizing the plant’s natural defense mechanism as a pre-plant soil biopesticide treatment (http://ibn.fm/RhJAF).
MustGrow’s signature products are shown to deliver effective pathogen and pest control to ensure plant growth and high yields in a variety of agricultural settings (http://ibn.fm/7JqnU). MustGrow is also testing the potential application of its technology in the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020, and for nematode biocontrol in the global tobacco industry.
Previous research findings made in collaboration with Virginia Tech’s Southern Piedmont Agricultural Research and Extension Center on the safety and efficacy of MustGrow’s patented granular organic biopesticide as a natural pre-plant soil treatment are encouraging, leading to a new research program, according to a news release (http://ibn.fm/GIIq6). The R&D effort targets tobacco cyst nematodes, a parasitic ringworm that has been reported in 11 tobacco-producing countries on four continents.
Based on MustGrow’s promising scientific achievements and research, advance corporate collaboration discussions are now underway with tobacco industry leaders. The recent appointment of Altria Group veteran Brian Quigley to MustGrow’s board of directors illustrates the company’s belief that there is significant opportunity to seek approval of MustGrow’s second generation liquid technology as an organic biopesticide for eventual use by tobacco growers (http://ibn.fm/Ymlqh).
For more information, visit the company’s website at www.MustGrow.ca
NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://ibn.fm/MGRO
